Prevalence of APC resistance and its relationship to arterial and venous thromboembolism in a general population sample of elderly Swedish men: The Study of Men Born in 1913
Open Access
- 1 June 1999
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 245 (6) , 593-600
- https://doi.org/10.1046/j.1365-2796.1999.00471.x
Abstract
Hansson P‐O, Eriksson E, Welin L, Eriksson H (Sahlgrenska University Hospital‐ÖSTRA, Göteborg, Sweden). Prevalence of APC resistance and its relationship to arterial and venous thromboembolism in a general population sample of elderly Swedish men: The Study of Men Born in 1913. J Intern Med 1999; 245: 593–600.Background. Most studies of hereditary resistance to activated protein C (APC resistance) as a risk factor for venous thromboembolism are derived from case–control studies of hospitalized patients, whilst the importance of this condition in the general population has been only sparsely investigated.Objective. To study the prevalence of APC resistance and its relationship to morbidity and mortality in a general population sample of elderly men.Design. Cross‐sectional and prospective follow‐up study.Setting. General community: The Study of Men Born in 1913.Subjects. A random population sample of 404 men, all 75 years of age.Main outcome measures. Four hundred and four men participated in a screening examination in 1988. The APC ratio was analysed in 382 of them. All the men were followed up for 5 years. Medical records were reviewed for all the men with a history of deep vein thrombosis, pulmonary embolism, myocardial infarction or stroke.Results. Twenty‐five men (6.5%) were found to have APC resistance. The incidence of venous thromboembolism, myocardial infarction or stroke did not differ between men with or without APC resistance, either retrospectively or during follow‐up. Only two men experienced a deep vein thrombosis before the age of 80 and there was no case of pulmonary embolism. Mortality during 5 years of follow‐up did not differ between men with and without APC resistance.Conclusion. The prevalence of APC resistance was 6.5% in this study of Swedish men. Although the size of the population sample is somewhat small, the study shows that, amongst elderly men, the association between APC resistance and venous thromboembolic disease was weak and men with this hereditary condition did not have any increase in morbidity or mortality compared with men without APC resistance.Keywords
This publication has 30 references indexed in Scilit:
- The G1691A mutation of the coagulation factor V gene (factor V Leiden) is rare in Chinese: an analysis of 618 individualsHuman Genetics, 1996
- Activated Protein C Resistance in Ischemic Stroke Not Due to Factor V Arginine 506 →Glutamine MutationStroke, 1996
- Prevalence of factor V gene mutation amongst myocardial infarction patients and healthy controls is higher in Sweden than in other countriesJournal of Internal Medicine, 1996
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosisThe Lancet, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Registration of myocardial infarction in the city of Göteborg, Sweden: A community studyJournal of Chronic Diseases, 1975
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958